JAMES DICKSON: Open Payments
NPI 1568475002 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,604 in 97 payments from 10 companies in 2025. Trend: 2023 $1,477 · 2024 $1,283 · 2025 $1,604
Food & beverage: $1,604
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 34 | $520 |
| ABBVIE INC. | 33 | $448 |
| Otsuka America Pharmaceutical, Inc. | 6 | $115 |
| Axsome Therapeutics, Inc. | 6 | $112 |
| Alkermes, Inc. | 5 | $106 |
| Lundbeck LLC | 4 | $104 |
| Bausch Health US, LLC | 4 | $82 |
| Vanda Pharmaceuticals Inc. | 3 | $71 |
| Medline Industries LP | 1 | $30 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: CAPLYTA, VRAYLAR, REXULTI, Auvelity, LYBALVI, APLENZIN, FANAPT, ARISTADA.
Industry payments across TX — which companies pay providers there.
